Literature DB >> 22766691

The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems.

Ann F Garland1, Lauren Brookman-Frazee, Emily Gray.   

Abstract

Studies have documented increased psychoactive medication use rates among children, but little is known about what child and/or family characteristics predict medication treatment in community-based care. This study examines the role of parent characteristics in children's medication treatment, while accounting for other potential predictors. Participants included 213 children ages 4-13 with disruptive behavior problems. Medication treatment was assessed by parent report; potential predictors of medication treatment, including child characteristics and parent characteristics (e.g., education level, perceived strain and psychopathology) were assessed at service intake. Over 60 % of children used a psychoactive medication during the 16 month study period (most commonly stimulants). Parent education level and reported strain were significant predictors of children's medication treatment even when accounting for other significant predictors such as child diagnosis, age, race/ethnicity, etc. Results highlight the role that parent characteristics have in accessing community-based medication treatment for children with disruptive behavior problems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766691      PMCID: PMC3517686          DOI: 10.1007/s10597-012-9514-1

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  36 in total

Review 1.  Research-practice gaps in child mental health.

Authors:  John D McLENNAN; C Nadine Wathen; Harriet L MacMILLAN; John N Lavis
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-06       Impact factor: 8.829

2.  The effectiveness of an experimental treatment when compared to care as usual depends on the type of care as usual.

Authors:  Nicolle M H van de Wiel; Walter Matthys; Peggy T Cohen-Kettenis; Gerard H Maassen; John E Lochman; Herman van Engeland
Journal:  Behav Modif       Date:  2007-05

3.  Psychotropic medication patterns among youth in foster care.

Authors:  Julie M Zito; Daniel J Safer; Devadatta Sai; James F Gardner; Diane Thomas; Phyllis Coombes; Melissa Dubowski; Maria Mendez-Lewis
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

Review 4.  Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Authors:  Jonathan Ipser; Dan J Stein
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

5.  Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.

Authors:  Joseph Biederman; Thomas J Spencer; Jeffrey H Newcorn; Haitao Gao; Denái R Milton; Peter D Feldman; Michael M Witte
Journal:  Psychopharmacology (Berl)       Date:  2006-11-09       Impact factor: 4.530

6.  Psychotropic prescriptions in a sample including both healthy and mood and disruptive disordered preschoolers: relationships to diagnosis, impairment, prescriber type, and assessment methods.

Authors:  Joan L Luby; Melissa Meade Stalets; Andy C Belden
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-04       Impact factor: 2.576

Review 7.  Evidence-based psychosocial treatments for children and adolescents with disruptive behavior.

Authors:  Sheila M Eyberg; Melanie M Nelson; Stephen R Boggs
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

8.  3-year follow-up of the NIMH MTA study.

Authors:  Peter S Jensen; L Eugene Arnold; James M Swanson; Benedetto Vitiello; Howard B Abikoff; Laurence L Greenhill; Lily Hechtman; Stephen P Hinshaw; William E Pelham; Karen C Wells; C Keith Conners; Glen R Elliott; Jeffery N Epstein; Betsy Hoza; John S March; Brooke S G Molina; Jeffrey H Newcorn; Joanne B Severe; Timothy Wigal; Robert D Gibbons; Kwan Hur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-08       Impact factor: 8.829

9.  Racial and ethnic disparities in caregiver strain and the use of child mental health services: a structural equation model.

Authors:  Sunny Hyucksun Shin; Timothy A Brown
Journal:  Psychiatr Serv       Date:  2009-08       Impact factor: 3.084

10.  Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.

Authors:  Elizabeth Pappadopulos; Peter S Jensen; Alanna R Chait; L Eugene Arnold; James M Swanson; Laurence L Greenhill; Lily Hechtman; Shirley Chuang; Karen C Wells; William Pelham; Thomas Cooper; Glenn Elliott; Jeffrey H Newcorn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

View more
  4 in total

1.  Does Patient Race/Ethnicity Influence Physician Decision-Making for Diagnosis and Treatment of Childhood Disruptive Behavior Problems?

Authors:  Ann F Garland; Robin Taylor; Lauren Brookman-Frazee; Mary Baker-Ericzen; Rachel Haine-Schlagel; Yi Hui Liu; Sarina Wong
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-17

2.  Psychotropic Medication Use by Children with Autism Served in Publicly Funded Mental Health Settings.

Authors:  Barbara Caplan; Colby Chlebowski; Gina May; Mary J Baker-Ericzén; Willard Connor; Lauren Brookman-Frazee
Journal:  J Dev Behav Pediatr       Date:  2021-11-30       Impact factor: 2.988

3.  Factor Structure of the Parent-Report Mood and Feelings Questionnaire (MFQ) in an Outpatient Mental Health Sample.

Authors:  Megan Jeffreys; Michelle Rozenman; Araceli Gonzalez; Erin M Warnick; Christine Dauser; Lawrence Scahill; Joseph Woolston; V Robin Weersing
Journal:  J Abnorm Child Psychol       Date:  2016-08

4.  Clinical predictors of antipsychotic use in children and adolescents with autism spectrum disorders: a historical open cohort study using electronic health records.

Authors:  Johnny Downs; Matthew Hotopf; Tamsin Ford; Emily Simonoff; Richard G Jackson; Hitesh Shetty; Robert Stewart; Richard D Hayes
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-10-15       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.